The FDA approved a new drug called COBENFY for schizophrenia treatment in adults, offering a novel approach to managing the disorder. This marks a significant advancement in the field after several decades and traditional treatments not meeting all patients' needs. The medication showed improvement in clinical trials with manageable side effects.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing